Oxidative stress and antioxidant status in patients with late-onset gestational diabetes mellitus
详细信息 查看全文
- 作者：Cristina López-Tinoco (1)
Mar Roca (3)
Amor García-Valero (1)
Mora Murri (3)
Francisco J. Tinahones (3)
Carmen Segundo (1)
José L. Bartha (2)
Manuel Aguilar-Diosdado (1) (4) - 关键词：Gestational diabetes mellitus ; Markers of oxidative stress ; Pregnancy
- 刊名：Acta Diabetologica
- 出版年：2013
- 出版时间：April 2013
- 年：2013
- 卷：50
- 期：2
- 页码：201-208
- 全文大小：199KB
- 参考文献：1. Ben-Haroush A, Yogev Y, Hod M (2004) Epidemiology of gestational diabetes mellitus and its association with type 2 diabetes. Diabetic Med 21:103-13 CrossRef
2. Ostlund I, Hanson U, Bj?rklund A et al (2003) Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care 26:2107-111 CrossRef
3. Albareda M, Caballero A, Badell G et al (2003) Diabetes and abnormal glucose tolerance in women with previous gestational diabetes. Diabetes Care 26:1199-205 CrossRef
4. Catalano PM, Huston L, Amini SB, Kalhan SC (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes. Am J Obstet Gynecol 180:903-16 CrossRef
5. Homko C, Sivan E, Chen X, Reece EA, Boden G (2001) Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J Clin Endocrinol Metab 86:568-73 CrossRef
6. Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA (1999) Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes 48:848-54 CrossRef
7. Metzger BE, The Organizing Committee (1991) Summary and recommendations of the 3rd international workshop-conference on gestational diabetes mellitus. Diabetes Care 40(Supp 2):197-01
8. Festa A, D’Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation 102:42-7 CrossRef
9. Bo S, Menato G, Gallo ML, Bardelli C et al (2004) Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand 83:335-40
10. Bartha JL, González-Bugatto F, Fernández-Macías R, González-González NL, Comino-Delgado R, Hervías-Vivancos B (2008) Metabolic syndrome in normal and complicated pregnancies. Eur J Obstet Gynecol Reprod Biol 137:178-84 CrossRef
11. Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-20 CrossRef
12. Maddux BA, See W, Lawrence JC, Goldfine AL, Goldfine ID, Evans JL (2001) Protection against oxidative stress-induced insulin resistance in rat L6 muscle cells by mircomolar concentrations of alpha-lipoic acid. Diabetes 50:404-10 CrossRef
13. Chen K, Thomas SR, Keaney JF (2003) Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic Biol Med 35:117-32 CrossRef
14. Ceriello A, Motz E (2004) Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24:816-23 CrossRef
15. Dr?ge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47-5
16. Haddad JJ (2002) Oxygen homeostasis, thiol equilibrium and redox regulation of signalling transcription factors in the alveolar epithelium. Cell Signal 14:799-10 CrossRef
17. Barnes PJ, Karin M (1997) Nuclear factor-kB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-071 CrossRef
18. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341-348
19. Santilli F, Cipollone F, Mezzetti A, Chiarelli F (2004) The role of nitric oxide in the development of diabetic angiopathy. Horm Metab Res 36:319-35 CrossRef
20. Basta G, Schmidt AM, DeCaterina R (2004) Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63:582-92 CrossRef
21. Esposito K, Nappo F, Marfella R et al (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106:2067-072 CrossRef
22. Marfella R, Esposito K, Giunta R et al (2000) Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation 101:2247-251 CrossRef
23. Ceriello A, Quagliaro L, Piconi L et al (2004) Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes 53:701-10 CrossRef
24. Januszewski AS, Alderson NL, Metz TO, Thorpe SR, Baynes JW (2003) Role of lipids in chemical modification of proteins and development of complications in diabetes. Biochem Soc Trans 31:1413-416 CrossRef
25. Jenkins AJ, Best JD, Klein RL, Lyons TJ (2004) Lipoproteins, glycoxidation and diabetic angiopathy. Diabetes Metab Res Rev 20:349-68 CrossRef
26. Baynes JW, Thrope SR (1999) Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 48:1- CrossRef
27. Viana M, Herrera E, Bonet B (1996) Teratogenic effects of diabetes mellitus in the rat. Prevention by vitamin E. Diabetologia 39:1041-046 CrossRef
28. Peuchant E, Brun JL, Rigalleau V et al (2004) Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin Biochem 37:293-98 CrossRef
29. Chaudhari L, Tandon OP, Vaney N, Agarwal N (2003) Lipid peroxidation and antioxidant enzymes in gestational diabetics. Indian J Physiol Pharmacol 47:441-46
30. Rajdl D, Racek J, Steinerova A, Novotny Z, Stozicky F, Trefil L (2005) Markers of oxidative stress in diabetic mothers and their infants during delivery. Physiol Res 54:429-36
31. Orhan H, ?nderoglu L, Yücel A, Sahin G (2003) Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet 267:189-95
32. Toescu V, Nuttall SL, Martin U (2004) Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci 106:93-8 CrossRef
33. Karacay ?, Sepici-Dincel A, Karcaaltincaba D et al (2010) A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24-6?weeks of gestation. Diabetes Res Clin Pract 89:231-38 CrossRef
34. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-057
35. Solomon CG, Willett WC, Carey VJ et al (1997) A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 278:1078-083 CrossRef
36. Montelongo A, Lasuncion MA, Pallardo LF, Herrera E (1992) Longitudinal study of plasma lipoprotein and hormones during pregnancy in normal and diabetic women. Diabetes 41:1651-659 CrossRef
37. Koukko E, Watts GF, Lowy C (1996) Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J Clin Pathol 49:634-37 CrossRef
38. American Diabetes Association (1996) Gestational diabetes mellitus. Diabetes Care 27:88-0
39. Herranz L, Villaroel A, Riesco G et al (2003) Elective delivery in women with gestational diabetes mellitus. Diabetología 46:A248–A249 - 作者单位：Cristina López-Tinoco (1)
Mar Roca (3)
Amor García-Valero (1)
Mora Murri (3)
Francisco J. Tinahones (3)
Carmen Segundo (1)
José L. Bartha (2)
Manuel Aguilar-Diosdado (1) (4)
1. Department of Endocrinology, Hospital Puerta del Mar, Cádiz, Spain
3. Department of Endocrinology, Hospital Virgen de la Victoria, Málaga, Spain
2. Department of Gynaecoloy, Hospital Puerta del Mar, Cádiz, Spain
4. Servicio de Endocrinología y Nutrición, Hospital Puerta del Mar, Av. Ana de Viya 21, 11009, Cádiz, Spain - ISSN：1432-5233
文摘
The relationship between late-onset gestational diabetes mellitus [GDM] and oxidative stress is not well known, and the importance of the oxidant/antioxidant equilibrium in the clinical evolution and its complications require elucidation. The aim of the study was to evaluate the relationships between maternal levels of markers of oxidative stress in women with late-onset GDM that, potentially, may have considerable clinical implications in the pathogenesis and/or the evolution of GDM. Pregnant women (n?=?78; 53 with GDM, 25 controls), between the 24th and 29th week of gestation, were enrolled. Both groups were analysed for demographic data, perinatal and obstetrics outcomes together with the levels of the marker’s oxidative stress and antioxidant status. Control versus patient results in the univariate analysis were the following: pre-gestational body mass index [BMI] 23.31?±?4.2 vs. 27.13?±?4.6?kg/m2 (P?=?0.001); weeks at delivery 39.2?±?3.05 vs. 38.9?±?1.8 (P?=?0.09); Caesarean delivery 12.5 vs. 43% (P?=?0.004); macrosomia 4 vs. 9.4% (P?=?0.6); lipoperoxides [LPO] 2.06?±?1.00 vs. 3.14?±?1.55?μmol/mg (P?=?0.001); catalase 3.23?±?1.41 vs. 2.52?±?1.3?nmol/min/ml (P?=?0.03); superoxide dismutase [SOD] 0.11?±?0.04 vs. 0.08?±?0.01?U/ml (P?=?0.0003); glutathione peroxidase [GPX] 0.03?±?0.006 vs. 0.025?±?0.006?nmol/min/ml (P?=?0.01); glutathione reductase [GSH] 0.004?±?0.002 vs. 0.004?±?0.004?nmol/min/ml (P?=?0.9)]; and glutathione transferase [GST] 0.0025?±?0.0012 vs. 0.0027?±?0.00017?nmol/min/ml (P?=?0.7). Multivariate analysis showed catalase might have a protective effect against GDM development and LPO seems to be a risk factor for the disease. These data suggest an increase in oxidative stress and a decrease in antioxidative defence in women with late-onset GDM and, as such, may have considerable clinical implications in the pathogenesis and/or the course of the pregnancy in these patients.